{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:48:56Z","timestamp":1760608136735},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,5,5]],"date-time":"2004-05-05T00:00:00Z","timestamp":1083715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,5,5]],"date-time":"2004-05-05T00:00:00Z","timestamp":1083715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/s00262-004-0532-x","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T14:24:58Z","timestamp":1083680698000},"page":"817-824","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100209-217 and gp100209-217T210M"],"prefix":"10.1007","volume":"53","author":[{"given":"Dirk","family":"Nagorsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Servis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,5,5]]},"reference":[{"key":"532_CR1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI117399","volume":"94","author":"Bhardwaj","year":"1994","unstructured":"Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM (1994) Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest 94:797\u2013807","journal-title":"J Clin Invest"},{"key":"532_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1471-4914(01)02101-3","volume":"7","author":"Bhardwaj","year":"2001","unstructured":"Bhardwaj N (2001) Processing and presentation of antigen by dendritic cells: implications for vaccines. Trends Mol Med 7:388\u2013394","journal-title":"Trends Mol Med"},{"key":"532_CR3","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","volume":"153","author":"Sette","year":"1994","unstructured":"Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J et al (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153:5586\u20135592","journal-title":"J Immunol"},{"key":"532_CR4","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.154.8.3961","volume":"154","author":"Kawakami","year":"1995","unstructured":"Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X,Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 154:3961\u20133968","journal-title":"J Immunol"},{"key":"532_CR5","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","volume":"91","author":"Kawakami","year":"1994","unstructured":"Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA (1994) Identification of a human melanoma antigen recognized by tumor- infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A 91:6458\u20136462","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"Rosenberg","year":"1998","unstructured":"Rosenberg SA, Yang JC, Schwartzentruber D, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dufour E, Schwartzberg L, Spiess P, Wunderlich J, Parkhurst MR, Kawakami Y, Seipp C, Einhorn JH, White D (1998) Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4:321\u2013327","journal-title":"Nat Med"},{"key":"532_CR7","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.157.6.2539","volume":"157","author":"Parkhurst","year":"1996","unstructured":"Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y (1996) Improved induction of melanoma reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201 binding residues. J Immunol 157:2539\u20132548","journal-title":"J Immunol"},{"key":"532_CR8","first-page":"4749","volume":"56","author":"Salgaller","year":"1996","unstructured":"Salgaller ML, Marincola FM, Cormier JN, Rosenberg SA (1996) Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides. Cancer Res 56:4749\u20134757","journal-title":"Cancer Res"},{"key":"532_CR9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/sj.gt.3302066","volume":"10","author":"Nagorsen","year":"2003","unstructured":"Nagorsen D, Panelli MC, Dudley ME, Seiter S, Finkelstein SE, Rosenberg SA, Marincola FM (2003) Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells. Gene Ther 10:1754\u20131765","journal-title":"Gene Ther"},{"key":"532_CR10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.17.1.739","volume":"17","author":"Rock","year":"1999","unstructured":"Rock KL, Goldberg AL (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 17:739\u2013779","journal-title":"Annu Rev Immunol"},{"key":"532_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(02)80012-8","volume":"80","author":"Rock","year":"2002","unstructured":"Rock KL, York IA, Saric T, Goldberg AL (2002) Proteasome degradation and the generation of MHC class I-presented petides. Adv Immunol 80:1\u201370","journal-title":"Adv Immunol"},{"key":"532_CR12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1021\/ac00125a006","volume":"58","author":"Knecht","year":"1986","unstructured":"Knecht R, Chang J-Y (1986) Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Anal Chem 58:2375\u20132379","journal-title":"Anal Chem"},{"key":"532_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00002371-200107000-00012","volume":"24","author":"Dudley","year":"2001","unstructured":"Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, Leitman SF, Rosenberg SA (2001) Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 24:363\u2013373","journal-title":"J Immunother"},{"issue":"3","key":"532_CR14","first-page":"155","volume":"2","author":"J Hakenberg","year":"2003","unstructured":"Hakenberg J, Nussbaum AK, Schild H, Rammensee HG, Kuttler C, Holzh\u00fctter H-G, Kloetzel P-M, Kaufmann SHE, Mollenkopf H-J (2003) MAPPP: MHC class I antigenic peptide processing prediction. Applied Bioinformatics 2(3)155\u2013158","journal-title":"Applied Bioinformatics"},{"key":"532_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/protein\/15.4.287","volume":"15","author":"Kesmir","year":"2002","unstructured":"Kesmir C, Nussbaum AK, Schild H, Detours V, Brunak S (2002) Prediction of proteasome cleavage motifs by neural networks. Protein Eng 15(4):287\u2013296","journal-title":"Protein Eng"},{"key":"532_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1006\/jmbi.2000.3683","volume":"298","author":"Kuttler","year":"2000","unstructured":"Kuttler C, Nussbaum AK, Dick TP, Rammensee HG, Schild H, Hadeler KP (2000) An algorithm for the prediction of proteasomal cleavages. J Mol Biol 298:417\u2013429","journal-title":"J Mol Biol"},{"key":"532_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s002510100300","volume":"53","author":"Nussbaum","year":"2001","unstructured":"Nussbaum AK, Kuttler C, Hadeler KP, Rammensee HG, Schild H (2001) PaProC: a prediction algorithm for proteasomal cleavages available on the WWW.Immunogenetics 53:87\u201394","journal-title":"Immunogenetics"},{"key":"532_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0952791502000043","volume":"15","author":"Nussbaum","year":"2003","unstructured":"Nussbaum AK, Kuttler C, Tenzer S, Schild H (2003) Using the World Wide Web for prediciting CTL epitopes. Curr Opin Immunol 15:49\u201374","journal-title":"Curr Opin Immunol"},{"key":"532_CR19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.20011974","volume":"195","author":"Schultz","year":"2002","unstructured":"Schultz ES, Chapiro J, Lurquin C, Claverol S, Burlet-Schiltz O, Warnier G, Russo V, Morel S, Levy F, Boon T, Van den Eynde BJ, van der Bruggen P (2002) The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J Exp Med 195(4):391\u2013399","journal-title":"J Exp Med"},{"key":"532_CR20","first-page":"2433","volume":"58","author":"Loftus","year":"1998","unstructured":"Loftus DJ, Squarcina P, Nielsen MB, Geisler C, Castelli C, Odum N, Appella E, Parmiani G, Rivoltini L (1998) Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma\/melanocyte epitope MART1(27\u201335). Cancer Res 58:2433\u20132439","journal-title":"Cancer Res"},{"key":"532_CR21","first-page":"301","volume":"59","author":"Rivoltini","year":"1999","unstructured":"Rivoltini L, Squarcina P, Loftus D, Castelli C, Tarsini P, Mazzocchi A, Rini F, Viggiano V, Belli F, Parmiani G (1999) A superagonist variant of peptide MART-1\/Melan A27\u201335 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implications for more effective immunotherapy. Cancer Res 59:301\u2013306","journal-title":"Cancer Res"},{"key":"532_CR22","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","volume":"160","author":"Valmori","year":"1998","unstructured":"Valmori D, Fonteneau JF, Lizana CM, Gervois N, Lienard D, Rimoldi D, Jongeneel CV, Jotereau F, Cerottini J-C, Romero P (1998) Enhanced generation of specific tumor-reactive CTL in vitro by selected MelanA\/MART-1 immunodominant peptide analogues. J Immunol 160:1750\u20131758","journal-title":"J Immunol"},{"key":"532_CR23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4049\/jimmunol.164.2.1125","volume":"164","author":"Valmori","year":"2000","unstructured":"Valmori D, Levy F, Miconnet I, Zajac P, Spagnoli GC, Rimoldi D, Lienard D, Cerundolo V, Cerottini JC, Romero P (2000) Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue. J Immunol 164:1125\u20131131","journal-title":"J Immunol"},{"key":"532_CR24","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1093\/intimm\/11.12.1971","volume":"11","author":"Valmori","year":"1999","unstructured":"Valmori D, Fonteneau JF, Valitutti S, Gervois N, Dunbar R, Lienard D, Rimoldi D, Cerundolo V, Jotereau F, Cerottini JC, Speiser DE, Romero P (1999) Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. Int Immunol 11:1971\u20131980","journal-title":"Int Immunol"},{"key":"532_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(00)80161-2","volume":"12","author":"Chen","year":"2000","unstructured":"Chen W, Anton LC, Bennink JR, Yewdell JW (2000) Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12(1):83\u201393","journal-title":"Immunity"},{"key":"532_CR26","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.4049\/jimmunol.162.6.3566","volume":"162","author":"Men","year":"1999","unstructured":"Men Y, Miconnet I, Valmori D, Rimoldi D, Cerottini JC, Romero P (1999) Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201\/Kb transgenic mice. J Immunol 162(6):3566\u20133573","journal-title":"J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-004-0532-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0532-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:12:04Z","timestamp":1684858324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-004-0532-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,5]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1007\/s00262-004-0532-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,5]]},"assertion":[{"value":"23 December 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}